Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

Table 1 Adverse drug events which were reported

Studies	Adverse events reported	Follow up period
Bolli2008	Peripheral edema, headache, nasopharyngitis, back pain, dizziness, diarrhea	52 weeks
Garber2006	Any AE, peripheral edema, weight increased, headache, dizziness, nausea	24 weeks
Kim2010	Any AE, nasopharyngitis, dizziness, headache, upper respiratory infection, headache	24 weeks
Rosenstock2007	Any AE, nasopharyngitis, dizziness, headache, upper respiratory tract infection, peripheral edema, weight gain	24 weeks
Rosenstock2009	Any AE, Nasopharyngitis, dizziness, upper respiratory tract infection, arthralgia, back pain, headache, nausea, diarrhea, peripheral edema, weight increased	104 weeks

Abbreviations: UTI urinary tract infection, SAEs serious adverse events, AE adverse event

ISSN: 2050-6511